CSIMarket Company Name, Ticker, Suppliers, else..


Xilio Therapeutics Inc   (NASDAQ: XLO)
Other Ticker:  
 

Xilio Therapeutics Inc

XLO's Fundamental analysis



Looking into Xilio Therapeutics Inc growth rates, revenue grew in IV. Quarter 2024 from the same quarter a year ago. Ranking at No. 2672

Major Pharmaceutical Preparations industry recorded growth of revenues by 11.85 %

Xilio Therapeutics Inc net loss decreased from $-18 millions, to $-13 millions in IV. Quarter 2024,

• More on XLO's Growth


Xilio Therapeutics Inc
realized a net loss in trailing twelve months.

Company is currently trading with Price to Cash flow multiple of 4.11 in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 6.98.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.27.


• More on XLO's Valuation
 
 Total Debt (Millions $) -
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ 99,125
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) -
 Tangible Book Value (Per Share $) 0.33

Xilio Therapeutics Inc
realized net loss in trailing twelve months.

Company is currently trading with Price to Cash flow multiple of 4.11 in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 6.98.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.27.

Xilio Therapeutics Inc Price to Book Ratio is at 2.52 lower than Industry Avg. of 79.76. and higher than S&P 500 Avg. of 0.01

• More on XLO's Valuation

•  Market Capitalization (Millions $) 44
•  Shares Outstanding (Millions) 53
•  Employees 64
•  Revenues (TTM) (Millions $) 6
•  Net Income (TTM) (Millions $) -58
•  Cash Flow (TTM) (Millions $) 11
•  Capital Exp. (TTM) (Millions $) 0
•  Total Debt (Millions $) -
•  Dividend TTM ($) 0 $
•  Dividend Yield TTM (%) -
•  Revenue/Employee (TTM) $ 99,125
•  Net Income/Employee(TTM) $ -
•  Receivable Turnover Ratio (TTM) -
•  Tangible Book Value (Per Share $) 0.33

•  Market Capitalization (Millions $) 44
•  Shares Outstanding (Millions) 53
•  Employees 64
•  Revenues (TTM) (Millions $) 6
•  Net Income (TTM) (Millions $) -58
•  Cash Flow (TTM) (Millions $) 11
•  Capital Exp. (TTM) (Millions $) 0





  Ratio
•   Capital Ratio (MRQ) 2.31
•  Total Debt to Equity (MRQ) -
•  Tangible Leverage Ratio (MRQ) 2.58
•  Asset Turnover Ratio (TTM) 0.08
•  Inventory Turnover Ratio (TTM) -





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com